Opus Genetics Virtual R&D Science Forum Scheduled for Tuesday, June 16, 2026, at 10:00 am ETUpcoming Data Readout for Cohort 1 of OPGx-BEST1 ...
Corteva’s planned spinoff company Vylor will keep its global headquarters in Johnston, a move Iowa leaders say strengthens ...
Experts in auditing, governance, and public administration have warned that poor record keeping is worsening tax disputes, ...
National Eye Institute (NEI) scientists have found that the way the retina metabolizes glucose directly controls which genes get switched on and off in light-sensing photoreceptors. The findings ...
Opus Genetics, Inc. (NASDAQ:IRD) is one of the best performing small cap stocks so far in 2026. On April 28, Citizens ...
Gov. Kim Reynolds announced Tuesday that Vylor, a future independent seed and genetics company being spun off from Corteva, ...
The Food and Drug Administration accepted Opus Genetics's investigational gene therapy into its Rare Disease Evidence Principles program, the company said Monday. The clinical-stage biopharmaceutical ...
Returning to its Iowa roots, Corteva seed spinoff Vylor will move its headquarters to Johnston from Indianapolis, the company ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...
Preparing to split into two businesses, Corteva Agrisciences has chosen Indianapolis as the headquarters for New Corteva, its business for crop protection and nature-inspired technologies, and ...
Opus Genetics Inc. (NASDAQ:IRD) is one of the best performing NASDAQ stocks according to Wall Street analysts.
The results, published May 5 in Nature Genetics, offer a new way to understand the molecular roots of cancer — an especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results